1.29
Health Catalyst Inc stock is traded at $1.29, with a volume of 261.86K.
It is up +0.00% in the last 24 hours and down -1.53% over the past month.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
See More
Previous Close:
$1.29
Open:
$1.31
24h Volume:
261.86K
Relative Volume:
0.35
Market Cap:
$95.32M
Revenue:
$311.14M
Net Income/Loss:
$-177.97M
P/E Ratio:
-0.5093
EPS:
-2.5329
Net Cash Flow:
$-20.82M
1W Performance:
+8.40%
1M Performance:
-1.53%
6M Performance:
-45.34%
1Y Performance:
-64.71%
Health Catalyst Inc Stock (HCAT) Company Profile
Name
Health Catalyst Inc
Sector
Industry
Phone
801-708-6800
Address
10897 SOUTH RIVER FRONT PARKWAY, #300, SOUTH JORDAN
Compare HCAT vs VEEV, BTSG, TEM, HQY, HNGE
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
HCAT
Health Catalyst Inc
|
1.29 | 95.32M | 311.14M | -177.97M | -20.82M | -2.5329 |
|
VEEV
Veeva Systems Inc
|
160.17 | 25.83B | 3.20B | 908.91M | 1.39B | 5.4168 |
|
BTSG
Brightspring Health Services Inc
|
58.50 | 11.25B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
46.18 | 8.35B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
88.11 | 7.25B | 1.31B | 215.20M | 408.32M | 2.4627 |
|
HNGE
Hinge Health Inc
|
55.25 | 4.27B | 646.34M | -512.40M | 202.76M | -6.6871 |
Health Catalyst Inc Stock (HCAT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-18-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Aug-27-25 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-11-25 | Downgrade | Citigroup | Buy → Neutral |
| Aug-08-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jun-17-25 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-09-25 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-08-25 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-10-24 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Jan-03-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-13-23 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-23 | Upgrade | Piper Sandler | Neutral → Overweight |
| Aug-01-23 | Initiated | Cantor Fitzgerald | Overweight |
| May-10-23 | Downgrade | Guggenheim | Buy → Neutral |
| May-10-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Apr-20-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Apr-12-23 | Initiated | Stephens | Equal-Weight |
| Apr-04-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-03-23 | Downgrade | Evercore ISI | Outperform → In-line |
| Oct-31-22 | Initiated | Wells Fargo | Equal Weight |
| Oct-25-22 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Sep-13-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Aug-05-22 | Downgrade | JP Morgan | Overweight → Neutral |
| Aug-05-22 | Downgrade | Stifel | Buy → Hold |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Mar-17-22 | Upgrade | Jefferies | Hold → Buy |
| Feb-11-22 | Initiated | Goldman | Buy |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Oct-14-21 | Initiated | BTIG Research | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Dec-08-20 | Initiated | Berenberg | Buy |
| Jul-14-20 | Initiated | Citigroup | Buy |
| Jun-18-20 | Initiated | Stifel | Buy |
| Jun-15-20 | Resumed | Evercore ISI | Outperform |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Outperform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Apr-02-20 | Initiated | Canaccord Genuity | Buy |
| Dec-20-19 | Initiated | Raymond James | Strong Buy |
| Oct-30-19 | Initiated | Cantor Fitzgerald | Overweight |
| Aug-19-19 | Initiated | Evercore ISI | Outperform |
| Aug-19-19 | Initiated | Goldman | Buy |
| Aug-19-19 | Initiated | JP Morgan | Overweight |
| Aug-19-19 | Initiated | Piper Jaffray | Overweight |
| Aug-19-19 | Initiated | SVB Leerink | Outperform |
| Aug-19-19 | Initiated | SunTrust | Buy |
| Aug-19-19 | Initiated | William Blair | Outperform |
View All
Health Catalyst Inc Stock (HCAT) Latest News
Health Catalyst Inc (HCAT) Share Price Today | Health Catalyst (HCAT) Live NSE/BSE - Value Research
Health Catalyst Q1 2026 Results: Revenue Decline, Client Migration Issues, and Strategic ShiftsNews and Statistics - IndexBox
EDGAR Filing Documents for 0001636422-25-000010 - SEC.gov
MongoDB, Health Catalyst, and Qualys Shares Are Soaring, What You Need To Know - Yahoo Finance
5 Insightful Analyst Questions From Health Catalyst’s Q1 Earnings Call - Yahoo Finance
Health Catalyst (HCAT) seeks declassification vote; board, auditor and pay proposals - Stock Titan
Health Catalyst stock (US42226A1079): Shares jump after recent trading update - AD HOC NEWS
3 Stocks With Recent Gains But Weak Fundamentals, According to May 2026 Analysis - IndexBox
5 insightful analyst questions from Health Catalyst’s Q1 earnings call - MSN
Health Catalyst outlines $260M-$265M 2026 revenue outlook backed by Project Nexus $30M run-rate savings - MSN
Health Catalyst stock (US42226A1079): Earnings update keeps focus on path to profitability - AD HOC NEWS
Health Catalyst Inc stock (US42226A1079): earnings update keeps focus on AI-driven healthcare analyt - AD HOC NEWS
Health Catalyst (HCAT) Stock Trades Up, Here Is Why - Yahoo Finance
Number of shareholders of Health Catalyst, Inc. – DUS:2YP - TradingView
Health Catalyst (NASDAQ: HCAT) group reports 8.3% stake in amended 13G/A - Stock Titan
Health Catalyst (HCAT) Q1 2026 Earnings Transcript - AOL.com
Health Catalyst stock (US42226A1079): Q1 beat with EPS of $0.02, revenue $70.76M - AD HOC NEWS
Healthcare Analytics Market is projected to Hit USD 47.97 - openPR.com
Health Catalyst Q1 2026 Earnings Preview - MSN
Analysts Offer Insights on Healthcare Companies: Health Catalyst (HCAT), Liquidia Technologies (LQDA) and Bicara Therapeutics Inc. (BCAX) - The Globe and Mail
Health Catalyst (HCAT) Reports Q1: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
HCAT SEC FilingsHealth Catalyst 10-K, 10-Q, 8-K Forms - Stock Titan
Health Catalyst(HCAT) Stock Options Chain | Quotes & News - Moomoo
Health Catalyst Is Maintained at Equal-Weight by Stephens & Co. - Moomoo
Health Catalyst Price Target Cut to $1.75/Share From $2.00 by Stephens & Co. - Moomoo
HCAT Maintained by Stephens & Co. -- Price Target Lowered to $1. - GuruFocus
Health Catalyst, Inc. (NASDAQ:HCAT) Q1 2026 Earnings Call Transcript - Insider Monkey
Health Catalyst Inc (HCAT) Q1 2026 Earnings Call Highlights: Sur - GuruFocus
Health Catalyst Sees 2026 Rev $260M-$265M >HCAT - Moomoo
Stifel Maintains Health Catalyst(HCAT.US) With Hold Rating, Maintains Target Price $2 - Moomoo
Health Catalyst (HCAT) Q1 earnings and revenues surpass estimates - MSN
Health Catalyst Q1 Earnings Call Highlights - inkl
Health Catalyst (HCAT) Reports Strong Q1 Revenue and Strategic T - GuruFocus
HCAT Forecasts FY26 Adjusted EBITDA Between $30 Million and $33 - GuruFocus
Earnings call transcript: Health Catalyst Q1 2026 revenue beats forecast - Investing.com UK
HCAT Financials: Income Statement, Balance Sheet & Cash Flow | Health Catalyst - Stock Titan
Earnings call transcript: Health Catalyst Q1 2026 revenue beats forecast By Investing.com - Investing.com Nigeria
Health Catalyst earnings matched, revenue topped estimates By Investing.com - Investing.com Canada
Health Catalyst (HCAT) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
Compared to Estimates, Health Catalyst (HCAT) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Health Catalyst, Inc. 1Q 2026: Revenue $70.76M, EPS ($1.53) — 10-Q Summary - TradingView
Health Catalyst (NASDAQ:HCAT) Q1 2026 Revenue Beat, Strategic Reset Fuel 11% Stock Surge - ChartMill
Health Catalyst Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Goodwill write-down drives wider Q1 2026 loss at Health Catalyst (HCAT) - Stock Titan
Q1 2026 Health Catalyst Inc Earnings Call Transcript - GuruFocus
HEALTH CATALYST ($HCAT) Releases Q1 2026 Earnings - Quiver Quantitative
Health Catalyst: Q1 Earnings Snapshot - marketscreener.com
Health Catalyst beats Q1 adjusted EBITDA expectations; net loss widens on impairment charge - TradingView
Health Catalyst Reports First Quarter 2026 Results - The Manila Times
Health Catalyst’s (NASDAQ:HCAT) Q1 CY2026 Sales Beat Estimates, Stock Jumps 11.1% - Yahoo Finance
Goodwill hit reshapes Health Catalyst (Nasdaq: HCAT) Q1 2026 results - Stock Titan
Health Catalyst Inc Stock (HCAT) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):